![]() ![]() Spinal Cord Stimulators (SCS) Market AnalysisĪs per DelveInsight, Spinal Cord Stimulators Market is expected to grow owing to the rise in chronic diseases worldwide. Moreover, the favorable insurance approval policies in developing countries and growing adoption rates due to its minimally invasive tendencies are expected to enhance the market potential of this equipment. The cost-saving opportunities with the use of rechargeable stimulators as compared to non-rechargeable ones are expected to lead to the high adoption of rechargeable devices. ![]() ![]() The “ Spinal Cord Stimulators Market ” report provides in-depth information into the market based on the segmentation such as by product type (rechargeable, non-rechargeable, others), by application (Failed Back Syndrome, Degenerative Disk Disease, Complex Regional Pain Syndrome, others), by end-user (hospitals, clinics, ambulatory surgical centers), and geography (North America, Europe, Asia-Pacific, and Rest of the World).Īs per DelveInsight’s assessment, rechargeable products will hold a major chunk of the market share in 2020. Spinal Cord Stimulators are mounted under the skin and transmit electrical signals of low levels of electricity directly into the spinal cord to relieve pain. Global Spinal Cord Stimulators (SCS): OverviewĪ spinal cord stimulator is an implanted device consisting of a thin wire which carries out current from the pulse generator to the nerve fibers of the spinal cord. The report also covers the key competitors and emerging devices in the domain. Some of the key MedTech giants in the Global Spinal Cord Stimulators Market include Boston Scientific Corporation, Medtronic PLC, Abbott Laboratories, Nevro Corp., Cirtec Medical, Stimwave LLC, NeuroSigma, Inc., Synapse Biomedical, Inc., Greatbatch, Inc., Saluda Medical Pty Ltd., Beijing PINS Medical Co., Ltd., and others.ĭelveInsight’s “ Spinal Cord Stimulators (SCS) Market ” research report provides the current and forecasted Spinal Cord Stimulators Market size, share, and trends analysis for the next five years, upcoming innovations in the segment, and major market drivers & barriers. Moreover, favorable government regulations for commercialization and launching products in the market and the rising geriatric population will also drive the Spinal Cord Stimulators Market. Some of the key factors, such as the growing number of patients with chronic pain and neuropathic pain and the launch of technologically advanced devices, are expected to boost the global Spinal Cord Stimulator (SCS) Market growth in the coming years. As per DelveInsight, the global Spinal Cord Stimulators (SCS) Market was valued at USD 2.25 billion in 2021 and growing at a CAGR of 8.70% during the forecast period (2022 to 2027) and is expected to reach USD 3.72 billion by 2027. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |